[Recent progress in chemotherapy for hepatocellular carcinoma].
Sakon
Masato
M
Nagano
Hiroaki
H
Monden
Morito
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D010478:Chemotherapy, Cancer, Regional Perfusion; D002945:Cisplatin / Q000008:administration & dosage; D018450:Disease Progression; D004317:Doxorubicin / Q000008:administration & dosage; D004347:Drug Interactions; D004621:Embolization, Therapeutic; D005472:Fluorouracil / Q000008:administration & dosage; D006498:Hepatectomy; D006801:Humans; D007261:Infusions, Intra-Arterial; D007262:Infusions, Intravenous; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects; D008113:Liver Neoplasms / Q000188:drug therapy*; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D000077150:Oxaliplatin; D013629:Tamoxifen / Q000627:therapeutic use; D005641:Tegafur / Q000008:administration & dosage; D014498:Uracil / Q000008:administration & dosage
D016898:Interferon-alpha; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D013629:Tamoxifen; D005641:Tegafur; D014498:Uracil; D004317:Doxorubicin; D002945:Cisplatin; D005472:Fluorouracil